- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Managed Care Minute: March 7, 2015
A one-minute look at managed care news during the week of March 2, 2015, including oral arguments for King v. Burwell and the approval of the first biosimilar in the United States.
The Supreme Court of the United States heard oral arguments for King v. Burwell this week, and at the end of the hearing the justices were clearly divided about the legality of tax subsidies for consumers on the federally facilitated marketplace.
In oncology news, the US now has its first biosimilar with the FDA approval of Sandoz’s Zarxio for some cancer patients, plus the National Cancer Institute’s director is stepping down.
Finally, The American Journal of Managed Care convened a panel of experts to discuss the role of formulary management in the changing dynamics for hepatitis C. Listen to the panel discussion here.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
